Cargando…
TFEB regulates sulfur amino acid and coenzyme A metabolism to support hepatic metabolic adaptation and redox homeostasis
Fatty liver is a highly heterogenous condition driven by various pathogenic factors in addition to the severity of steatosis. Protein insufficiency has been causally linked to fatty liver with incompletely defined mechanisms. Here we report that fatty liver is a sulfur amino acid insufficient state...
Autores principales: | Matye, David, Gunewardena, Sumedha, Chen, Jianglei, Wang, Huaiwen, Wang, Yifeng, Hasan, Mohammad Nazmul, Gu, Lijie, Clayton, Yung Dai, Du, Yanhong, Chen, Cheng, Friedman, Jacob E., Lu, Shelly C., Ding, Wen-Xing, Li, Tiangang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519740/ https://www.ncbi.nlm.nih.gov/pubmed/36171419 http://dx.doi.org/10.1038/s41467-022-33465-9 |
Ejemplares similares
-
Combining ASBT inhibitor and FGF15 treatments enhances therapeutic efficacy against cholangiopathy in female but not male Cyp2c70 KO mice
por: Hasan, Mohammad Nazmul, et al.
Publicado: (2023) -
An FGF15/19-TFEB regulatory loop controls hepatic cholesterol and bile acid homeostasis
por: Wang, Yifeng, et al.
Publicado: (2020) -
Glycine-β-Muricholic Acid Improves Liver Fibrosis and Gut Barrier Function by Reducing Bile Acid Pool Size and Hydrophobicity in Male Cyp2c70 Knockout Mice
por: Hasan, Mohammad Nazmul, et al.
Publicado: (2023) -
Cullin neddylation inhibitor attenuates hyperglycemia by enhancing hepatic insulin signaling through insulin receptor substrate stabilization
por: Chen, Cheng, et al.
Publicado: (2022) -
Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis
por: Matye, David J., et al.
Publicado: (2021)